Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market. It is the largest pharmaceutical company in India.
Sun Pharmaceuticals Industries Ltd reported Revenues for Q1FY24 of ₹11,941.00 Crores up from ₹10,762.00 Crore year on year, a rise of 10.96%.
Total Expenses for Q1FY24 of ₹9,341.00 Crores up from ₹8,479.00 Crores year on year, a rise of 10.17%.
Consolidated Net Profit of ₹2,006.00 Crores down 4.16% from ₹2,093.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹8.43, down 1.86% from ₹8.59 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,